Free Cancer Screening Guidelines
Brian Leyland-Jones: Now Is the Time!
“This is the transformative time in oncology,” heralds Brian Leyland-Jones, M.B., B.S., Ph.D., and there is no spin doctoring in the statement by the member of the National Foundation for Cancer Research’s scientific advisory board. From genomics to targeted therapies to vaccinations, the last 40 years has seen more strides…...
Albert Szent-Györgyi’s discovery of vitamin C
In a world of ever-changing fad diets, it can be difficult to pinpoint what exactly constitutes as proper nutrition. Luckily, there are some basic nutrition tips that everyone can agree on. It’s no secret that fruits and vegetables are the key to a well-balanced diet, regardless of the current fad.…...
Zhen-Yi Wang & Zhu Chen: Quite a Combination
There was a time when if you were diagnosed with acute promyelocytic leukemia, or APL, the prognosis was grim. First discovered in 1957, APL is a form of acute myeloid leukemia, where immature white blood cells called promyelocytes accumulate in the bone marrow. The overgrowth of promyelocytes leads to a…...
Carlo Croce: It’s All About (Trans)Location
“It was a great pleasure because it is so important,” recalls Carlo Croce, M.D., of his 2008 win of the National Foundation for Cancer Research’s Szent-Györgyi Prize for Progress in Cancer Research. “The committee is very selective, and they really want to choose outstanding people who really have made a…...
Alex Matter: Making Targeted Therapy a Reality
“I was attracted, even as a youngster, by infectious diseases and cancer,” recalls Alex Matter, M.D. That young boy would pursue these passions and, in adulthood, emerge as a leading global authority in the disease field. Now the CEO of the Agency for Science, Technology and Research, or A*STAR, the…...
Pioneering Physician-Scientist to Receive 2019 Szent-Györgyi Prize for Progress in Cancer Research
FOR IMMEDIATE RELEASE: February 12, 2019 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Programs & Communications E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 Awardee Has Remained at the Vanguard of Various Cancer Immunotherapy Fields for over Four Decades ROCKVILLE, MD – The National Foundation for Cancer Research…...
DOWNLOAD
